The researchers also found that TEP1 rs1760904 AG and AG/AA genotypes were statistically significantly associated with a reduced risk of prostate cancer compared to the GG genotype (p = 0.003; p = 0.005, respectively). Here, TEP1 is linked to prostate carcinoma.